Browse the full insider trade history of 강스템바이오텍, a listed equity based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Market capitalisation: €218.2bn. The latest transaction was disclosed on 12 March 2026 — Other. Among the most active insiders: 강스템바이오텍. The full history is openly available.